Avian Mycoplasmosis: Chronic Respiratory Disease in Poultry and Diagnostic Approaches

Introduction

Avian mycoplasmosis, principally caused by Mycoplasma gallisepticum, represents one of the most economically significant infectious diseases of poultry worldwide. The disease manifests as chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys, leading to reduced weight gain, decreased egg production, increased mortality, and substantial carcass condemnation at slaughter [1, 2]. M. gallisepticum is a member of the class Mollicutes, characterized by the absence of a cell wall and a reduced genome size, which limits its metabolic capacity and renders it dependent on host-derived nutrients [3]. This obligate parasitic lifestyle imposes specific challenges for in vitro cultivation and diagnostic detection.

The present article provides an exhaustive reference for veterinary practitioners, diagnostic laboratory personnel, and poultry health managers. It details the etiological agent, pathophysiological mechanisms, clinical presentation, and a comprehensive suite of diagnostic approaches ranging from classical culture to modern molecular typing methods such as multilocus sequence typing (MLST). Emphasis is placed on serological surveillance strategies and biosecurity interventions that form the cornerstone of control programs for M. gallisepticum infection in commercial poultry operations.

Etiology and Taxonomy

Mycoplasma gallisepticum belongs to the family Mycoplasmataceae within the class Mollicutes. The species is distinguished from other avian mycoplasmas (e.g., M. synoviae, M. meleagridis, M. iowae) by its pathogenic potential, antigenic profile, and genetic markers [4]. The organism is pleomorphic, typically appearing as coccoid or filamentous structures 0.2 to 0.5 μm in diameter, and lacks a peptidoglycan cell wall. This structural deficiency renders M. gallisepticum intrinsically resistant to beta-lactam antibiotics and explains its reliance on cholesterol incorporation into the cell membrane for stability [5].

The genome of M. gallisepticum strain R (high passage) is approximately 996 kilobase pairs with a G+C content of 31 mol% [6]. Key virulence-associated genes include those encoding cytadhesins (e.g., GapA, CrmA, MGC2) and the variable lipoprotein hemagglutinin (VlhA) family, which undergo phase and antigenic variation to evade host immune responses [7, 8]. This antigenic diversity complicates serological interpretation and vaccine development.

Pathogenesis and Host Interactions

Infection begins with inhalation of aerosolized M. gallisepticum droplets or direct contact with infected birds, fomites, or vertically infected eggs. The organism adheres specifically to ciliated epithelial cells of the upper respiratory tract via its cytadhesin complex [9]. Adhesion triggers a cascade of events: loss of ciliary motility, epithelial cell exfoliation, and infiltration of heterophils and mononuclear cells into the lamina propria. The resulting inflammatory exudate accumulates in the tracheal lumen, nasal passages, and air sacs, giving rise to the characteristic clinical signs of rales, coughing, and nasal discharge [10].

In the presence of concurrent viral infections (e.g., Newcastle disease virus, infectious bronchitis virus) or bacterial coinfections (e.g., Escherichia coli, Ornithobacterium rhinotracheale), the disease is exacerbated, a phenomenon often referred to as complicated CRD [11]. The synergistic interaction between M. gallisepticum and E. coli, for instance, results in severe airsacculitis, pericarditis, and perihepatitis. These coinfections are frequently encountered in field situations and underscore the importance of comprehensive diagnostic testing [12] (see also Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies).

Clinical Signs and Gross Pathology

The incubation period typically ranges from 6 to 21 days. In chickens, the primary manifestation is chronic respiratory disease characterized by progressive dyspnea, tracheal rales, sneezing, and ocular discharge. Infected layers exhibit a marked decline in egg production (10 to 30%) and an increase in shell quality abnormalities [13]. In turkeys, infectious sinusitis presents with infraorbital sinus swelling, mucopurulent discharge, and severe respiratory distress.

Gross pathological findings include catarrhal to fibrinous tracheitis, airsacculitis with foamy or caseous exudate, and, in advanced cases, fibrinous pericarditis and perihepatitis. Microscopically, the tracheal mucosa shows deciliation, epithelial hyperplasia, and lymphoid follicle formation (lymphoplasmacytic inflammation) [14]. Chronic infections may lead to atrophy of the bursa of Fabricius and thymus, contributing to immunosuppression [15].

Epidemiology and Transmission

M. gallisepticum is transmitted horizontally via direct bird-to-bird contact, aerosolized droplets, and contaminated feed, water, and equipment. Vertical transmission via the transovarian route is a well-documented mechanism, with infected breeder hens producing infected progeny [16]. The organism can survive for several hours in dust, feathers, and organic material, facilitating indirect spread between flocks on the same farm or via personnel and fomites.

Risk factors for introduction and spread include multi-age production systems, high stocking density, poor ventilation, and coinfection with other respiratory pathogens. Wild birds, particularly house sparrows and starlings, have been implicated as potential reservoirs and mechanical vectors [17]. Once introduced into a naïve flock, the infection spreads rapidly and tends to persist indefinitely without intervention.

Diagnostic Approaches

Accurate diagnosis of avian mycoplasmosis requires a combination of clinical observation, pathological examination, and laboratory testing. The table below summarizes the principal diagnostic methods.

Culture-Based Methods

Isolation of M. gallisepticum from tracheal swabs, choanal cleft swabs, air sac exudate, or sinus fluid remains the definitive diagnostic gold standard, although it is seldom used in rapid surveillance programs. Samples are inoculated into modified Frey's medium or Hayflick's agar supplemented with 10 to 15% horse or swine serum, 10% fresh yeast extract, 0.5% glucose, and 1000 U/mL penicillin to suppress bacterial contaminants [18]. Inoculated plates are incubated at 37°C in a 5% CO₂ atmosphere for up to 21 days. Typical colonies exhibit a "fried-egg" appearance with a central dense core of growth penetrating the agar and a peripheral zone of surface growth. Identification is confirmed by growth inhibition with specific antiserum, immunofluorescence, or PCR [19].

The principal drawbacks of culture are the slow growth rate and the requirement for specialized media and expertise. Sensitivity is compromised by prior antimicrobial therapy, improper sample handling, and overgrowth of faster-growing mycoplasmas or bacteria [20].

Serological Techniques

Serological surveillance is widely employed for flock-level screening and monitoring of M. gallisepticum status. The serum plate agglutination (RPA) test uses a stained antigen suspension; a positive reaction is indicated by visible agglutination within 2 minutes. RPA is rapid and inexpensive but is subject to false-positive reactions from cross-reacting antibodies, particularly with M. synoviae [21].

The hemagglutination inhibition (HI) test offers greater specificity and is often used as a confirmatory test for RPA-positive sera. The HI test measures the ability of antibodies to inhibit hemagglutination of chicken erythrocytes by M. gallisepticum antigen. The HI test requires paired sera to demonstrate a fourfold or greater rise in titer, indicative of recent infection [22].

Enzyme-linked immunosorbent assays (ELISA) have become the predominant serological tool due to their high sensitivity, objectivity, and automation compatibility. Commercial ELISA kits detect antibodies (predominantly IgY) against M. gallisepticum whole-cell or recombinant antigens. Results are expressed as sample-to-positive (S/P) ratios or titers, and flock-level interpretation (e.g., mean titer, seroprevalence) is used to infer infection status [23] (see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus for general ELISA principles). However, serology cannot distinguish vaccinated from naturally infected birds unless DIVA (Differentiating Infected from Vaccinated Animals) strategies employing specific antigens are applied.

Molecular Detection

Polymerase chain reaction (PCR) has largely supplanted culture for routine detection of M. gallisepticum due to its speed, sensitivity, and ability to detect non-viable organisms. Conventional PCR targets the mgc2 cytadhesin gene or the 16S rRNA gene, with product visualization via agarose gel electrophoresis [24]. Real-time quantitative PCR (qPCR) using TaqMan probes or SYBR Green provides quantitative data and eliminates post-amplification handling, reducing contamination risk. Multiplex qPCR panels that simultaneously detect M. gallisepticum, M. synoviae, and M. meleagridis are now standard in many diagnostic laboratories [25].

Molecular methods are particularly valuable for detecting carrier birds, early infections, and environmental samples. However, false negatives can occur if inhibitors are present in clinical specimens or if the sample is collected during a period of low shedding. Standardized nucleic acid extraction protocols and inclusion of internal amplification controls are essential for reliable results.

Multilocus Sequence Typing (MLST)

MLST provides a portable, sequence-based method for genotyping M. gallisepticum isolates and tracing transmission pathways. A standard MLST scheme for M. gallisepticum involves PCR amplification and sequencing of seven housekeeping gene fragments: adk, atpA, dnaK, efp, gapA, gmk, and lpdA [26]. Each unique allele combination defines a sequence type (ST). Dendrograms constructed from concatenated sequences reveal clonal complexes and population structure.

MLST has been instrumental in elucidating the global phylogeography of M. gallisepticum, demonstrating that certain STs are associated with specific geographic regions and host species [27]. Moreover, MLST has been used to confirm vertical transmission events and to distinguish field strains from vaccine strains. The high discriminatory power of MLST makes it superior to serotyping and more reproducible across laboratories compared to pulsed-field gel electrophoresis (PFGE) [28].

Advanced Genomic Tools

Whole-genome sequencing (WGS) using high-throughput sequencers provides the ultimate resolution for epidemiological investigations. Core genome MLST (cgMLST) and single nucleotide polymorphism (SNP) analysis can differentiate isolates that are indistinguishable by conventional MLST [29]. WGS also facilitates detection of antimicrobial resistance determinants (e.g., mutations in gyrA, parC, and 23S rRNA) and virulence gene content [30]. The cost of WGS is decreasing, and bioinformatics pipelines are becoming more accessible, positioning this technology for broader use in reference laboratories.

Diagnostic Algorithm and Decision Tree

The following Mermaid flowchart illustrates a recommended diagnostic algorithm for a poultry flock suspected of M. gallisepticum infection.

flowchart TD
    A[Flocks with respiratory signs or egg drop], > B{Sampling strategy}
    B, > C[Pooled tracheal swabs (5-10 birds)]
    B, > D[Serum samples (20-30 birds)]
    C, > E[Real-time PCR for MG/MS]
    D, > F[ELISA screening]
    E, > G{PCR positive?}
    G, >|Yes| H[Confirm with species-specific qPCR]
    G, >|No| I[Consider alternative diagnoses]
    H, > J[Obtain isolate via culture]
    J, > K[MLST or WGS for typing]
    F, > L{Seropositive flock?}
    L, >|Yes| M[Repeat ELISA in 2-4 weeks; check HI titer]
    L, >|No| N[No evidence of infection; monitor]
    M, > O{Titer rise?}
    O, >|Yes| P[Active infection likely; initiate control]
    O, >|No| Q[Possible past exposure or cross-reaction]
    P, > R[Biosecurity review and vaccination strategy]
    I, > S[Test for IBV, NDV, APEC, ORT, etc.]

Biosecurity and Control

Prevention of M. gallisepticum introduction and spread relies on rigorous biosecurity and management practices. Key measures include:

• Single-age production: Avoid mixing age groups on the same farm to break the transmission cycle.
• All-in/all-out stocking: Complete depopulation between flocks followed by cleaning, disinfection, and downtime of at least 2 weeks.
• Quarantine of new stock: All incoming birds should originate from certified M. gallisepticum-free sources and be serologically tested upon arrival [31].
• Dedicated footwear and clothing: Use of farm-specific boots and coveralls, with footbaths containing appropriate disinfectants (e.g., quaternary ammonium compounds, chlorhexidine) [32].
• Rodent and wild bird control: Prevent access of wild birds to poultry houses. Implement integrated pest management programs.
• Vaccination: Live attenuated vaccines (e.g., ts-11, 6/85) and bacterins are available. Vaccination reduces clinical signs and transmission but does not eliminate infection [33]. DIVA-compatible vaccines using antigenic markers are under development.

Antimicrobial therapy is rarely curative and is discouraged as a sole control measure due to the emergence of resistance. Tetracyclines, tylosin, and fluoroquinolones have been used, but MIC creep has been documented in several countries [34].

References

[1] Kleven SH. Mycoplasma gallisepticum infection. In: Swayne DE, et al., editors. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 907-929.

[2] Ley DH. Mycoplasma gallisepticum infection. In: Saif YM, editor. Diseases of Poultry. 12th ed. Blackwell; 2008. p. 807-834.

[3] Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Rev. 1998;62(4):1094-1156.

[4] Brown DR, Whitcomb RF, Bradbury JM. Revised minimal standards for description of new species of the class Mollicutes. Int J Syst Evol Microbiol. 2007;57(11):2703-2719.

[5] Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2003;83(2):417-432.

[6] Papazisi L, Gorton TS, Kutish G, et al. The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology. 2003;149(9):2307-2316.

[7] Goh MS, Gorton TS, Forsyth MH, et al. Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology. 1998;144(11):2971-2978.

[8] Noormohammadi AH, Markham PF, Kanci A, et al. A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma gallisepticum. Mol Microbiol. 2000;35(4):911-922.

[9] Winner F, Rosengarten R, Citti C. In vitro cell invasion of Mycoplasma gallisepticum. Infect Immun. 2000;68(7):4238-4244.

[10] Nunoya T, Tajima M, Yagihashi T, et al. Evaluation of respiratory lesions in chickens infected with Mycoplasma gallisepticum. Avian Dis. 1992;36(1):57-66.

[11] Gross WB. The development of respiratory disease in chickens infected with Mycoplasma gallisepticum and the effect of environmental stress. Avian Dis. 1990;34(2):324-332.

[12] Dho M, Gandrille C, Legoff F. The role of Escherichia coli in the respiratory disease complex of chickens. Vet Microbiol. 1992;31(1):1-10.

[13] Mohammed HO, Carpenter TE, Yamamoto R. Economic impact of Mycoplasma gallisepticum infections in laying hens. Avian Dis. 1987;31(3):511-517.

[14] Nunoya T, Yagihashi T, Tajima M, et al. Pathology of the air sacs in chickens infected with Mycoplasma gallisepticum. Avian Pathol. 1995;24(2):315-327.

[15] Gaunson JE, Philip CJ, Whithear KG, et al. The cellular immune response in the tracheal mucosa to Mycoplasma gallisepticum in vaccinated and unvaccinated chickens. Avian Pathol. 2006;35(2):123-131.

[16] Glisson JR, Kleven SH. Vertical transmission of Mycoplasma gallisepticum in turkeys. Avian Dis. 1988;32(4):739-743.

[17] Hartup BK, Kollias GV, Ley DH. Distribution of Mycoplasma gallisepticum in house finch populations. J Wildl Dis. 2001;37(1):1-9.

[18] Frey ML, Hanson RP, Anderson DP. A medium for the isolation of avian mycoplasmas. Am J Vet Res. 1968;29(11):2163-2171.

[19] Kleven SH. Identification of mycoplasmas using growth inhibition and immunofluorescence. In: Razin S, Tully JG, editors. Methods in Mycoplasmology. Academic Press; 1983. p. 99-106.

[20] Bradbury JM. Recovery of mycoplasmas from birds. In: Miles R, Nicholas R, editors. Mycoplasma Protocols. Humana Press; 1998. p. 45-52.

[21] Yoder HW. A comparison of the serum plate agglutination and hemagglutination inhibition tests for detecting Mycoplasma gallisepticum antibodies. Avian Dis. 1975;19(3):451-458.

[22] Kleven SH. Hemagglutination inhibition test. In: Swayne DE, editor. A Laboratory Manual for the Isolation and Identification of Avian Pathogens. 5th ed. AAVP; 2008. p. 117-119.

[23] Kempf I, Gesbert F, Guittet M. Comparison of three serological tests for detection of antibodies to Mycoplasma gallisepticum. Avian Pathol. 1994;23(1):125-133.

[24] Garcia M, Ikuta N, Levisohn S, et al. Development and application of a polymerase chain reaction for detection of Mycoplasma gallisepticum. Avian Dis. 1995;39(4):725-734.

[25] Raviv Z, Kleven SH. The development of a real-time PCR assay for detection of Mycoplasma gallisepticum. J Vet Diagn Invest. 2004;16(6):577-581.

[26] El Gazzar M, Ghanem M, McDonald R, et al. Multilocus sequence typing of Mycoplasma gallisepticum isolates from poultry and wild birds. Vet Microbiol. 2011;148(1):57-64.

[27] Kiss I, Matiz K, Kaszanyitzky E, et al. Application of multilocus sequence typing to the characterization of Mycoplasma gallisepticum strains from Hungary. J Vet Diagn Invest. 2011;23(3):488-493.

[28] Ball C, Forrester A, Ghanem M, et al. Comparison of pulsed-field gel electrophoresis and multilocus sequence typing for differentiation of Mycoplasma gallisepticum isolates. Avian Pathol. 2013;42(5):437-443.

[29] Ghanem M, El Gazzar M. Core genome multilocus sequence typing for high-resolution genotyping of Mycoplasma gallisepticum. mSystems. 2018;3(2):e00194-17.

[30] Lysnyansky I, Gerchman I, Levisohn S, et al. Molecular characterization of acquired antimicrobial resistance in Mycoplasma gallisepticum. Antimicrob Agents Chemother. 2008;52(9):3220-3226.

[31] Kleven SH. Control of avian mycoplasma infections in commercial poultry. Avian Dis. 2008;52(3):367-374.

[32] Marois C, Dufour-Gesbert F, Kempf I. Detection of Mycoplasma gallisepticum in poultry house dust. Avian Pathol. 2000;29(6):527-532.

[33] Whithear KG. Control of avian mycoplasmosis by vaccination. Rev Sci Tech. 1996;15(4):1527-1543.

[34] Gautier-Bouchardon AV. Antimicrobial resistance in Mycoplasma gallisepticum: a review. Vet Sci. 2019;6(1):21.

[35] Levisohn S, Kleven SH. Avian mycoplasmosis (Mycoplasma gallisepticum). Rev Sci Tech. 2000;19(2):425-442.

[36] Stipkovits L, Kempf I. Mycoplasmoses in poultry. Rev Sci Tech. 1996;15(4):1495-1525.

[37] Bradbury JM, Amer MM. Avian mycoplasma infections. Vet Clin North Am Food Anim Pract. 1987;3(1):95-110.

[38] Yoder HW. Avian mycoplasmosis. In: Hofstad MS, editor. Diseases of Poultry. 7th ed. Iowa State University Press; 1978. p. 288-327.

[39] Kleven SH. Mycoplasma gallisepticum in poultry: a review. Avian Pathol. 2008;37(5):453-462.

[40] Kempf I, Guittet M, Bennejean G. Mycoplasmoses aviaires. Point Vet. 1994;26(156):29-36.

[41] Ley DH, Berkhoff JE. Mycoplasma gallisepticum in turkeys: clinical and pathologic aspects. Avian Dis. 1990;34(2):392-399.

[42] Nunoya T, Otaki Y, Tajima M. Ultrastructural changes in tracheal epithelium of chickens infected with Mycoplasma gallisepticum. J Comp Pathol. 1991;105(2):131-142.

[43] Soeripto KL, Whithear KG, Cottew GS. Virulence of Mycoplasma gallisepticum strains. Avian Dis. 1979;23(4):862-872.

[44] Jordan FT. Avian mycoplasma infections. Vet Rec. 1985;116(15):399-402.

[45] Bencina D, Mrzel I, Dorrer D. Evaluation of the hemagglutination inhibition test for detection of Mycoplasma gallisepticum antibodies. Avian Dis. 1987;31(3):509-516.

[46] Feberwee A, Mekkes DR, de Wit JJ. Comparison of serological tests for detection of antibodies to Mycoplasma gallisepticum. Avian Pathol. 2005;34(4):349-353.

[47] Gorton TS, Geary SJ. Sequence analysis of the Mycoplasma gallisepticum genome. Nucleic Acids Res. 2004;32(7):2187-2197.

[48] May M, Brown DR. Diversity of Mycoplasma gallisepticum strains in house finches. J Wildl Dis. 2008;44(4):910-920.

[49] Raviv Z, Kleven SH. Rapid detection of Mycoplasma gallisepticum in suspected flocks. Avian Dis. 2005;49(2):261-265.

[50] Sluis HJ. Biosecurity in poultry production. World Poult Sci J. 2003;59(1):71-82.